title: [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber syndrome)].
authors: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors: Anne-Christin
authors: AC
authors: Stöwhas
authors: Irene
authors: I
authors: Guldenschuh
authors: Gustav
authors: G
authors: Andreisek
authors: Christlieb
authors: C
authors: Haller
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D003937:Diagnosis, Differential; D004844:Epistaxis / Q000209:etiology / Q000235:genetics / Q000628:therapy; D017707:Erythrocyte Transfusion; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000235:genetics / Q000628:therapy; D006469:Hemoptysis / Q000209:etiology / Q000628:therapy; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000175:diagnosis / Q000235:genetics; D008099:Liver / Q000098:blood supply; D008168:Lung / Q000098:blood supply; D008279:Magnetic Resonance Imaging; D008297:Male; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000175:diagnosis* / Q000235:genetics; D014057:Tomography, X-Ray Computed; D018616:Ultrasonography, Doppler, Duplex
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab